Kuriakose CK, Chandiraseharan VK, John AO, Bal D, Jeyaseelan V, Sudarsanam TD. End-of-life decisions: A retrospective study in a tertiary care teaching hospital in India. Indian J Med Res. 2019 Dec;150(6):598-605. doi: 10.4103/ijmr.IJMR_1409_17. PMID: 32048623; PMCID: PMC7038812.

Janeela MA, Oommen A, Misra AK, Ramya I. Paraquat poisoning: Case report of a survivor. J Family Med Prim Care. 2017 Jul-Sep;6(3):672-673. doi: 10.4103/2249-4863.222042. PMID: 29417032; PMCID: PMC5787979.

John AO, Paul H, Vijayakumar S, Anandan S, Sudarsan T, Abraham OC, Balaji V. Mortality from acinetobacter infections as compared to other infections among critically ill patients in South India: A prospective cohort study. Indian J Med Microbiol. 2020 Jan-Mar;38(1):24-31. doi: 10.4103/ijmm.IJMM_19_492. PMID: 32719205. Link

Manesh A, John AO, Mathew B, Varghese L, Rupa V, Zachariah A, Varghese GM. Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis. Mycoses. 2016 Dec;59(12):765-772. doi: 10.1111/myc.12529. Epub 2016 Jul 22. PMID: 27443253.

Mathew N, Joel A, Andrews AG, John AO, Singh A. CDK 4/6 inhibitor induced lung injury: a case report and review of literature. Ecancermedicalscience. 2021 Jun 7;15:1245. doi: 10.3332/ecancer.2021.1245. PMID: 34267801; PMCID: PMC8241445.

Thomas Z, Jambunathan P, Jibi A, John AO, Singh A. Low-dose nivolumab and cabozantinib in recurrent intestinal-type papillary adenocarcinoma of the sinonasal region. BMJ Case Rep. 2023 Nov 3;16(11):e255021. doi: 10.1136/bcr-2023-255021. PMID: 37923331; PMCID: PMC10626912.

Kuriakose CK, Chandiraseharan VK, John AO, Bal D, Jeyaseelan V, Sudarsanam TD. End-of-life decisions: A retrospective study in a tertiary care teaching hospital in India. Indian J Med Res. 2019 Dec;150(6):598-605. doi: 10.4103/ijmr.IJMR_1409_17. PMID: 32048623; PMCID: PMC7038812.

Janeela MA, Oommen A, Misra AK, Ramya I. Paraquat poisoning: Case report of a survivor. J Family Med Prim Care. 2017 Jul-Sep;6(3):672-673. doi: 10.4103/2249-4863.222042. PMID: 29417032; PMCID: PMC5787979.

John AO, Paul H, Vijayakumar S, Anandan S, Sudarsan T, Abraham OC, Balaji V. Mortality from acinetobacter infections as compared to other infections among critically ill patients in South India: A prospective cohort study. Indian J Med Microbiol. 2020 Jan-Mar;38(1):24-31. doi: 10.4103/ijmm.IJMM_19_492. PMID: 32719205. Link

Manesh A, John AO, Mathew B, Varghese L, Rupa V, Zachariah A, Varghese GM. Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis. Mycoses. 2016 Dec;59(12):765-772. doi: 10.1111/myc.12529. Epub 2016 Jul 22. PMID: 27443253.

Mathew N, Joel A, Andrews AG, John AO, Singh A. CDK 4/6 inhibitor induced lung injury: a case report and review of literature. Ecancermedicalscience. 2021 Jun 7;15:1245. doi: 10.3332/ecancer.2021.1245. PMID: 34267801; PMCID: PMC8241445.

Thomas Z, Jambunathan P, Jibi A, John AO, Singh A. Low-dose nivolumab and cabozantinib in recurrent intestinal-type papillary adenocarcinoma of the sinonasal region. BMJ Case Rep. 2023 Nov 3;16(11):e255021. doi: 10.1136/bcr-2023-255021. PMID: 37923331; PMCID: PMC10626912.

Singh A, Georgy JT, Joel A, Thumaty DB, John AO, Ramnath N, George TK, Sharma P, Patole S, Rebekah G, Sigamani E, Manipadam MT, Cherian AJ, Abraham DT, Paul MJ, Balakrishnan R, Sebastian P, Backianathan S, Chacko RT. Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer. Cancer Invest. 2023 Oct;41(9):789-802. doi: 10.1080/07357907.2023.2278048. Epub 2023 Nov 17. PMID: 37909664.

John AO, Ramnath N. Neoadjuvant Versus Adjuvant Systemic Therapy for Early-Stage Non-Small Cell Lung Cancer: The Changing Landscape Due to Immunotherapy. Oncologist. 2023 Sep 7;28(9):752-764. doi: 10.1093/oncolo/oyad125. PMID: 37338126; PMCID: PMC10485299.